Australia's largest stock trading and investment forum Australia's #1 stock forum

SRX HHL

4$ 'Even if doctors don't know whether their patients have been...

First 62 Last

Share
Profile

Follow
cafa

8,917 Posts.

32

12/03/15

18:52

Post #: 14904897
Share

Originally posted by fourdollars ↑

That's something I posited a while ago .... the theory that you can "blind" a trial but can't "blind" the results. Even if doctors don't know whether their patients have been given the spheres, if they end up improving or living longer than expected, they'd be speculating that their patient was given the drug and that it works ...

PS: On the "UBS has now reviewed the results of earlier trials to get to its probability of success and $50 valuation", wouldn't you be a pit p***ed off as a client? I mean the timing of the SIRFLOX trial reporting and the results of earlier trials have been available for over two years. Why do the research now, when you could have done it when the SP was about $12?

Expand

4$
'Even if doctors don't know whether their patients have been given the spheres,'

I'm not sure about this. The managing oncologist would know which go on the trial? I don't think they are injecting placebo into the patients, surely?

I may have the wrong handle on this.

Cheers

HHL Price at posting: $2.43 Sentiment: None Disclosure: Not Held

SRX Price at posting: $39.13 Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

BUX

Buxton projects new graphite province discovery at WA Narryer play

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

There are more pages in this discussion • 71 more messages in this thread...

First 62 Last

Add SRX (ASX) to my watchlist